These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20796157)

  • 41. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H; Cooper C; Murphy T; Klein MB
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage.
    Mansour-Ghanaei F; Mehrdad M; Mortazavi S; Joukar F; Khak M; Atrkar-Roushan Z
    Ann Hepatol; 2012; 11(5):667-71. PubMed ID: 22947527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.
    Salkic NN; Jovanovic P; Hauser G; Brcic M
    Am J Gastroenterol; 2014 Jun; 109(6):796-809. PubMed ID: 24535095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients.
    Cross TJ; Burroughs AK; Harrison PM
    Liver Transpl; 2010 Jun; 16(6):789-90; author reply 791-2. PubMed ID: 20517916
    [No Abstract]   [Full Text] [Related]  

  • 48. [Noninvasive assessment of liver fibrosis in chronic hepatitis B using a predictive model].
    Zhang WS; Wang BE; Wang TL; Ou XJ; Chen Y; Li Q; Wang XM; Qian LX; Ma H; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):169-73. PubMed ID: 16556408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
    Wai CT; Greenson JK; Fontana RJ; Kalbfleisch JD; Marrero JA; Conjeevaram HS; Lok AS
    Hepatology; 2003 Aug; 38(2):518-26. PubMed ID: 12883497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
    Cross TJ; Rizzi P; Berry PA; Bruce M; Portmann B; Harrison PM
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):730-8. PubMed ID: 19430302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Wang H; Xu H; Qu L; Wang X; Wu R; Gao X; Jin Q; Niu J
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):997-1002. PubMed ID: 27167453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Toson el-SA; Shiha GE; El-Mezayen HA; El-Sharkawy AM
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):931-9. PubMed ID: 27159125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
    Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
    Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Do prothrombin time, transaminases, and platelet count predict the severity of fibrosis in viral liver diseases?].
    Mohamed MA; Majda E; Mohamed K; Bechir Z; Sana K; Ehsène BB; Samia C
    Tunis Med; 2005 Jul; 83(7):400-3. PubMed ID: 16220696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.